The decisions of the Board of Directors, 28 march 2017

Nexstim Plc (NXTMH:HEX, NXTMS:STO), a medical technology company aiming to improve rehabilitation for stroke patients through the use of non-invasive brain stimulation, announces that the Board of Directors of Nexstim Plc. has today, in the meeting that took place after the Annual General Meeting, elected the members of the Board Committees as follows:

  The chairman of the Audit Committee shall be Juliet Thompson and the members shall be Rohan J. Hoare and Tomas Holmberg.

The chairman of the Remuneration committee shall be Ken Charhut and the members shall be Rohan J. Hoare and Martin Jamieson.

The chairman of the Nomination Committee shall be Sami Tuhkanen.


Martin Jamieson, chairman and CEO

Further information

Martin Jamieson, Chief Executive Officer

UB Securities Oy (Certified Adviser)
+358 (0)9 2538 0246

Citigate Dewe Rogerson
Katja Stout
+44 (0)207 2821066

About Nexstim Plc

Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system as the first and only FDA-cleared and CE-marked navigated Transcranial Magnetic Stimulation (nTMS) system for pre-surgical mapping of the motor and speech cortices. Based on the same technology platform, the Company has developed a system called Navigated Brain Therapy (NBT®) which is CE-marked for chronic neuropathic pain, major depression and stroke therapy. Nexstim's shares are listed on Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit

Media contact

Citigate Dewe Rogerson

David Dible / Isabelle Andrews / Shabnam Bashir
3 London Wall Buildings
London Wall

Tel: +44 (0) 207 2822949